抗体与药物合物的治疗指数的改善
Hans-Peter Gerber1, Sanjeev Gangwar1, Alison Betts2,3
1Department of Research and Development, Codeable Therapeutics, Palo Alto, CA, USA.
mAbs
|July 6, 2023
概括
与化疗相比,抗体药物合物 (ADC) 的抗瘤活性优于化疗,不仅是由于最大耐受剂量 (MTD),而且由于较低的最小有效剂量 (MED). 这个修订后的模型解释了ADC的有效性,并指导了未来的开发.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 抗体-药物合物 (ADC) 是一类有前途的向癌症治疗药物.
- 之前的研究重点是ADC的最大耐受剂量 (MTD) 与它们的细胞毒性有效载荷相比.
- 科伦博和里奇质疑ADC是否真的会增加对应的小分子/化疗的MTD.
研究的目的:
- 为理解ADC抗瘤活性和治疗指数 (TI) 提出修订后的模型.
- 为了解释ADC与传统化疗相比,ADC的优异抗瘤反应.
- 为ADC设计和开发的未来进步提供框架.
主要方法:
- 对ADC及其相应化疗的临床和临床前数据的审查.
- 开发一个修订后的模型,将最小有效剂量 (MEDs) 与MTDs结合起来.
- 使用基于暴露的治疗指数 (TI) 计算方法.
主要成果:
- 抗癌药物表现出优异的抗瘤活性,不仅仅是由于MTDs,而且由于较低的MEDs.
- 基于暴露的TI计算方法有效地解释了ADCs的增强疗效.
- 修订后的图形表示,ADCs的TI比化疗更好.
结论:
- ADC的治疗疗效受MTD和MED的影响.
- 修订后的模型提供了更准确的ADC性能表示.
- 这个框架可以指导未来的蛋白质和化学工程努力,以优化ADCs.
更多相关视频
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
7.7K
11:02Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018
7.8K
相关概念视频
Therapeutic Index
4.4K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
4.4K
Phase II Conjugation Reactions: Overview
247
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
247
Drug Biotransformation: Overview
2.5K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.5K
